Featured Research

from universities, journals, and other organizations

Molecule Reduces Alzheimer Plaques In Brain, Researchers Report

Date:
May 2, 2001
Source:
University Of California, San Francisco
Summary:
The highways and byways through which the brain exchanges messages require maintenance much as any municipal road. Crucial to these thoroughfares are the trash collectors, which prevent the accumulation of toxic waste. What would happen if such debris were left to accumulate? Alzheimer's disease would result. Now, researchers at the Gladstone Institute of Neurological Disease and the Department of Neurology at the University of California, San Francisco (UCSF) have identified a molecule that could be key to getting trash-collecting cells, called microglia, back to work.

The highways and byways through which the brain exchanges messages require maintenance much as any municipal road. Crucial to these thoroughfares are the trash collectors, which prevent the accumulation of toxic waste. What would happen if such debris were left to accumulate? Alzheimer's disease would result.

Related Articles


Unfortunately, that scenario plays itself out over and over again in the brains of the four million Americans with the disease. Now, researchers at the Gladstone Institute of Neurological Disease and the Department of Neurology at the University of California, San Francisco (UCSF) have identified a molecule that could be key to getting trash-collecting cells, called microglia, back to work.

Called TGF-b1, the molecule stimulates microglial cells to action so they begin to clear away a toxic substance called b-amyloid, which accumulates in Alzheimer brains in the form of deposits, called plaques. Most surprising is that researchers had long viewed activated microglia primarily as the cells that incite inflammation and fuel the disease process.

"People always thought that inflammation and microglial activation were bad," said Tony Wyss-Coray, PhD, lead author, investigator at the Gladstone Institute of Neurological Disease and assistant professor of neurology at UCSF. "But we showed that, when stimulated by TGF-b1, microglial activities can be beneficial."

Wyss-Coray and his collaborators realized they were on to something when they measured Alzheimer-like changes in mice that were genetically engineered with the capability of producing both human b-amyloid and TGF-b1. Increased levels of TGF-b1 reduced the number of plaques by 75% and overall b-amyloid levels by 60%, compared to mice with normal levels of TGF-b1.

For confirmation, the investigators then took microglial cells and placed them in petri dishes along with b-amyloid. They then added TGF-b1 to some of the dishes. Eighteen hours later, they checked to see how much b-amyloid was left and found that TGF-b1 had triggered the microglia to destroy most of the b-amyloid in the dish, similar to what happened in the mice. The results are published in the May 2001 issue of the journal Nature Medicine.

Since TGF-b1 has many effects other than those revealed in this study, physicians probably won't be using TGF-b1 to treat patients. More promising would be to zero in on the molecules that microglia produce when they are stimulated by TGF-b1. Such factors could be useful for treating or preventing the accumulation of b-amyloid in Alzheimer's disease, Wyss-Coray explained.

Co-investigators on the study include Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease and Joseph B. Martin Distinguished Professor of Neuroscience at UCSF; Gladstone research associates Carol Lin, Fengrong Yan, Gui-Qiu Yu, and Michelle Rohde; Lisa McConlogue, PhD, staff scientist at Elan Pharmaceuticals; and, Eliezer Masliah, MD, professor of pathology and neurosciences at the University of California, San Diego.

This study was supported by grants from the National Institute on Aging and the Alzheimer's Association.

The Gladstone Institute of Neurological Disease is one of three research institutes that comprise The J. David Gladstone Institutes, a private biomedical research institution affiliated with UCSF. The institution is named for a prominent real estate developer who died in 1971. His will created a testamentary trust that reflects his long-standing personal interest in medical education and research.


Story Source:

The above story is based on materials provided by University Of California, San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Francisco. "Molecule Reduces Alzheimer Plaques In Brain, Researchers Report." ScienceDaily. ScienceDaily, 2 May 2001. <www.sciencedaily.com/releases/2001/05/010502075721.htm>.
University Of California, San Francisco. (2001, May 2). Molecule Reduces Alzheimer Plaques In Brain, Researchers Report. ScienceDaily. Retrieved February 27, 2015 from www.sciencedaily.com/releases/2001/05/010502075721.htm
University Of California, San Francisco. "Molecule Reduces Alzheimer Plaques In Brain, Researchers Report." ScienceDaily. www.sciencedaily.com/releases/2001/05/010502075721.htm (accessed February 27, 2015).

Share This


More From ScienceDaily



More Mind & Brain News

Friday, February 27, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Foods to Battle Stress

The Best Foods to Battle Stress

Buzz60 (Feb. 26, 2015) If you&apos;re dealing with anxiety, there are a few foods that can help. Krystin Goodwin (@krystingoodwin) has the best foods to tame stress. Video provided by Buzz60
Powered by NewsLook.com
Sleeping Too Much Or Too Little Might Increase Stroke Risk

Sleeping Too Much Or Too Little Might Increase Stroke Risk

Newsy (Feb. 26, 2015) People who sleep more than eight hours per night are 45 percent more likely to have a stroke, according to a University of Cambridge study. Video provided by Newsy
Powered by NewsLook.com
Mayor Says District of Columbia to Go Ahead With Pot Legalization

Mayor Says District of Columbia to Go Ahead With Pot Legalization

Reuters - News Video Online (Feb. 25, 2015) Washington&apos;s mayor says the District of Columbia will move forward with marijuana legalization, despite pushback from Congress. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Marijuana Nowhere Near As Deadly As Alcohol: Study

Marijuana Nowhere Near As Deadly As Alcohol: Study

Newsy (Feb. 25, 2015) A new study says marijuana is about 114 times less deadly than alcohol. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins